GetTopicDetailResponse(id=065a366421, topicName=BRAFV600E, introduction=BRAFV600E, content=null, image=null, comments=4, allHits=1129, url=https://h5.medsci.cn/topic?id=3664, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=37974, tagList=[TagDto(tagId=37974, tagName=BRAFV600E)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1989509, encodeId=82e7198950911, content=<a href='/topic/show?id=065a366421' target=_blank style='color:#2F92EE;'>#BRAFV600E#</a>, objectTitle=Clinical Colorectal Cancer:BRAF抑制劑encorafenib(康奈非尼)聯(lián)合西妥昔單抗治療經(jīng)治的BRAFV600E突變轉(zhuǎn)移性結(jié)直腸癌的療效, objectType=article, longId=727754, objectId=ef63e277540f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef63e277540f, replyNumber=0, likeNumber=101, createdTime=2022-08-25, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef63e277540f, moduleTitle=Clinical Colorectal Cancer:BRAF抑制劑encorafenib(康奈非尼)聯(lián)合西妥昔單抗治療經(jīng)治的BRAFV600E突變轉(zhuǎn)移性結(jié)直腸癌的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ef63e277540f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989508, encodeId=e14a1989508e9, content=<a href='/topic/show?id=065a366421' target=_blank style='color:#2F92EE;'>#BRAFV600E#</a>, objectTitle=Lancet Oncol：達(dá)拉菲尼聯(lián)合曲美替尼在BRAFV600E突變陽性膠質(zhì)瘤中的療效, objectType=article, longId=221246, objectId=2b0d221246c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d221246c4, replyNumber=0, likeNumber=90, createdTime=2022-06-04, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d221246c4, moduleTitle=Lancet Oncol：達(dá)拉菲尼聯(lián)合曲美替尼在BRAFV600E突變陽性膠質(zhì)瘤中的療效, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=2b0d221246c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989507, encodeId=4829198950e97, content=<a href='/topic/show?id=065a366421' target=_blank style='color:#2F92EE;'>#BRAFV600E#</a>, objectTitle=NEJM：Encodrafenib、Binimetinib聯(lián)合西妥昔單抗用于BRAFV600E突變結(jié)直腸癌, objectType=article, longId=181909, objectId=dfaf18190961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dfaf18190961, replyNumber=0, likeNumber=156, createdTime=2020-06-10, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dfaf18190961, moduleTitle=NEJM：Encodrafenib、Binimetinib聯(lián)合西妥昔單抗用于BRAFV600E突變結(jié)直腸癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dfaf18190961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989506, encodeId=5b341989506a5, content=<a href='/topic/show?id=065a366421' target=_blank style='color:#2F92EE;'>#BRAFV600E#</a>, objectTitle=JCO：甲狀腺乳頭狀癌患者年齡相關(guān)死亡風(fēng)險與BRAFV600E有關(guān), objectType=article, longId=123572, objectId=a8b11235e299, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8b11235e299, replyNumber=0, likeNumber=100, createdTime=2018-01-19, rootId=0, userName=changjitao2009, userId=db7c233, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8b11235e299, moduleTitle=JCO：甲狀腺乳頭狀癌患者年齡相關(guān)死亡風(fēng)險與BRAFV600E有關(guān), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a8b11235e299)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
